We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CRPOF market cap is 15.85M. The company's latest EPS is CAD 0.0562 and P/E is 4.80.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 11.59M | 12.88M | 15.12M | 17.2M | 18.84M |
| Operating Income | -1.57M | -326k | 2.35M | 2.62M | 5.5M |
| Net Income | -315k | -1.13M | 1.86M | 2.84M | 4.4M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 25.32M | 27.27M | 29.22M | 30.53M | 37.73M |
| Total Liabilities | 2.11M | 4.96M | 4.91M | 3.33M | 5.45M |
| Total Equity | 23.22M | 22.31M | 24.31M | 27.2M | 32.29M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -2.12M | 882k | 4.45M | 3.51M | 6.64M |
| Investing | -1.38M | -197k | -483k | -790k | -389k |
| Financing | -826k | -672k | -459k | -308k | -218k |
| Market Cap | 15.85M |
| Price to Earnings Ratio | 4.80 |
| Price to Sales Ratio | 1.12 |
| Price to Cash Ratio | 1.53 |
| Price to Book Ratio | 0.65 |
| Dividend Yield | - |
| Shares Outstanding | 78.29M |
| Average Volume (1 week) | 6.46k |
| Average Volume (1 Month) | 5.49k |
| 52 Week Change | -44.55% |
| 52 Week High | 0.4269 |
| 52 Week Low | 0.11464 |
| Spread (Intraday) | 0.07 (30.5%) |
| Company Name | Ceapro Inc (QX) |
| Address |
7824 - 51 avenue nw edmonton, alberta T6E 6W2 |
| Website | https://www.ceapro.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
